Related Experiment Videos
Identification and characterisation of C1q-binding phage displayed peptides
V Lauvrak1, O H Brekke, O Ihle
1Department of Biology, Biotechnology Centre of Oslo, University of Oslo, Norway.
Biological Chemistry
|February 14, 1998
Summary
Researchers identified C1q-binding peptides using phage display. These peptides suggest novel binding sites on complement receptor 3 (CR3) and may lead to new complement system therapies.
Area of Science:
- Immunology
- Molecular Biology
Background:
- The classical complement pathway, initiated by C1q, plays a crucial role in innate and adaptive immunity.
- Understanding C1q interactions is vital for modulating immune responses and developing targeted therapies.
Purpose of the Study:
- To identify novel C1q-binding peptides using phage display technology.
- To investigate potential C1q binding sites within complement receptor 3 (CR3).
Main Methods:
- Screening of five phage-displayed peptide libraries against C1q.
- Two rounds of panning to isolate and characterize C1q-binding peptides.
- Sequence analysis of isolated peptides for similarities to known protein domains.
Main Results:
- Isolation of several distinct C1q-binding peptides from all screened libraries.
- Identification of peptide groups with sequence similarity to integrin A-domain MIDAS and CD18.
- Evidence supporting the binding of CR3 (CD11b/CD18) to C1q and suggesting CR3 binding sites for C1q.
Conclusions:
- Phage display is effective for identifying C1q-binding peptides.
- Findings suggest novel interactions between CR3 and C1q, potentially involving specific peptide motifs.
- Identified peptides offer potential for developing C1q-modulating therapeutics.